Viatris Inc., a new kind of global healthcare company, today announced that Fortune has named the company fifth out of 53 on its Change the World list. The annual ranking showcases companies that have had a positive societal impact through activities that are part of their core business strategy. Viatris is featured on the listing for its work through public-private partnerships to expand access to innovative HIV drugs, particularly in low- and middle-income countries.
“We are honored that Viatris has been named to Fortune’s prestigious Change the World list. When we created Viatris nearly a year ago with the vision to see healthcare not as it is, but as it should be, we set out with a strong foundation in corporate social responsibility and a deep commitment to meeting some of the world’s most pressing health needs,” said Viatris Chief Executive Officer Michael Goettler. “Our efforts around expanding access to innovative HIV medicines is a great example of the positive impact we can make to provide sustainable access to high-quality medicine, regardless of geography or circumstance. Further, we believe our ability to apply this business model to other areas of unmet need, such as biosimilars access globally, is a unique value proposition for the stakeholders we serve.”
Viatris has operated as a catalyst not only to expand access to more affordable versions of existing antiretrovirals (ARVs) through licensing agreements with brand-innovator companies, but also to develop new therapies more suitable for patients in low- and middle-income countries. For example, we:
“Fortune’s recognition of Viatris’ contributions to help stem the tide of HIV/AIDS is humbling validation of the hard work that began 15 years ago when Mylan acquired Matrix and that has been sustained by the many passionate, focused and dedicated employees serving this patient community,” said Viatris President Rajiv Malik. “Today, we are proud to say we are the world’s largest supplier of antiretroviral medicines for HIV and more than 40% of people on treatment for HIV around the world use a Viatris product, the vast majority of which are in low- or lower-middle-income countries. This level of access would not be possible without innovative partnerships with a wide variety of organizations that share our access vision. Our being named on Fortune’s Change the World list is much more than Viatris – it’s a testament to the collaboration of researchers, funders, companies, NGOs, non-profits, policymakers and scientists working together to empower people worldwide to live healthier at every stage of life.”
Fortune Change the World List Methodology
The Change the World list is developed in collaboration with the Shared Value Initiative. This final list was selected and ranked by the editors of FORTUNE based on the magazine’s own reporting and analysis. View the complete methodology here.
Viatris Inc. is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris’ portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of more than 40,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com